Darktrace leaving London isn’t just ‘bad news’ for the LSE. It’s a crisis. April 26, 2024 Losing Darktrace to private equity must surely focus the minds of decision makers - this is a crisis
Senior: Demand fuels growth in aerospace business April 26, 2024 Senior said it expects that its aerospace business will see "good growth" this year due to the increasing number of aircrafts being built.
Freshly-listed World Chess sees revenue slip after Armageddon series but gaming firm still confident April 26, 2024 Online platform World Chess reported a slip in revenue for the year ended December, but said it was still confident in delivering its growth strategy.
Pearson ‘pleased’ with pivot to AI but Virtual Schools slow again April 26, 2024 Pearson is integrating artificial intelligence (AI) into its suite of educational products as it looks to modernise.
Loungers trading ahead of expectations as new site roll-out boosts bottom line April 26, 2024 Loungers has said it is trading ahead of expectations for the year, helped by the opening of 36 new sites.
London Stock Exchange Group boss set for payday despite take-private boom April 25, 2024 The London Stock Exchange Group was dealt a bloody nose by investors today after a chunk of its shareholders voted to reject a pay rise for chief executive David Schwimmer.
Mytilineos eyes potential dual listing in London April 25, 2024 Greek energy giant Mytilineos has said it is eyeing a potential secondary listing in London before the end of next year.
Focusrite: Music software company hits flat note as revenue falls £11m April 25, 2024 Focusrite's net debt more than doubled to £27.3m in the first half of the year, which it blamed on higher working capital levels.
Drugmaker Indivior seeks shareholder approval to move primary listing from London to New York April 25, 2024 Opioid dependence treatment maker Indivior has confirmed a plan to move its primary stock market listing from London to New York this summer in yet another blow to the capital's beleaguered bourse.
Hikma: Pharma giant starts year strong as new product sales surge in key markets April 25, 2024 In 2023, the group became the second-largest pharmaceutical company in Middle East and North Africa by sales.